LINEAGE CELL THERAPEUTICS IN's ticker is LCTX and the CUSIP is 53566P109. A total of 102 filers reported holding LINEAGE CELL THERAPEUTICS IN in Q1 2021. The put-call ratio across all filers is 2.57 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2023 | $2,103 | +350.3% | 1,402,123 | +251.4% | 0.00% | – |
| Q4 2022 | $467 | -99.9% | 399,039 | -21.2% | 0.00% | – |
| Q3 2022 | $572,000 | -64.5% | 506,313 | -50.4% | 0.00% | -100.0% |
| Q2 2022 | $1,612,000 | +486.2% | 1,020,446 | +471.7% | 0.00% | – |
| Q1 2022 | $275,000 | -66.3% | 178,493 | -46.4% | 0.00% | – |
| Q4 2021 | $816,000 | +1565.3% | 333,220 | +1615.4% | 0.00% | – |
| Q3 2021 | $49,000 | -98.5% | 19,425 | -98.6% | 0.00% | -100.0% |
| Q1 2021 | $3,351,000 | +437.0% | 1,425,776 | +301.9% | 0.00% | – |
| Q4 2020 | $624,000 | +86.3% | 354,753 | -0.8% | 0.00% | – |
| Q3 2020 | $335,000 | +2691.7% | 357,528 | +2417.8% | 0.00% | – |
| Q2 2020 | $12,000 | – | 14,200 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| BROADWOOD CAPITAL INC | 34,005,379 | $85,694,000 | 4.37% |
| Defender Capital, LLC. | 4,798,270 | $12,707,000 | 4.13% |
| Raffles Associates | 93,590 | $236,000 | 0.22% |
| Prescott General Partners LLC | 1,851,851 | $4,667,000 | 0.16% |
| DCF Advisers, LLC | 87,000 | $219,000 | 0.10% |
| Laidlaw Wealth Management LLC | 104,841 | $264,000 | 0.07% |
| Beirne Wealth Consulting Services, LLC | 45,000 | $113,000 | 0.06% |
| Strategic Wealth Investment Group, LLC | 70,625 | $179,000 | 0.05% |
| Fort Sheridan Advisors LLC | 47,931 | $121,000 | 0.04% |
| Sightline Wealth Advisors, LLC | 14,958 | $38,000 | 0.03% |